Romosozumab improves lumbar spine bone mass and bone strength parameters relative to alendronate in postmenopausal women: results from the Active‐Controlled Fracture Study in Postmenopausal Women With Osteoporosis at High Risk ( ARCH) trial
出版年份 2021 全文链接
标题
Romosozumab improves lumbar spine bone mass and bone strength parameters relative to alendronate in postmenopausal women: results from the Active‐Controlled Fracture Study in Postmenopausal Women With Osteoporosis at High Risk (
ARCH)
trial
作者
关键词
-
出版物
JOURNAL OF BONE AND MINERAL RESEARCH
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2021-07-01
DOI
10.1002/jbmr.4409
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Pharmacological Management of Osteoporosis in Postmenopausal Women: An Endocrine Society Guideline Update
- (2020) Dolores Shoback et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS/AMERICAN COLLEGE OF ENDOCRINOLOGY CLINICAL PRACTICE GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS— 2020 UPDATE EXECUTIVE SUMMARY
- (2020) Pauline M. Camacho et al. Endocrine Practice
- Pharmacological Management of Osteoporosis in Postmenopausal Women: An Endocrine Society* Clinical Practice Guideline
- (2019) Richard Eastell et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Change in Bone Density and Reduction in Fracture Risk: A Meta-Regression of Published Trials
- (2019) Mary L Bouxsein et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Bone Mechanical Properties in Healthy and Diseased States
- (2018) Elise F. Morgan et al. Annual Review of Biomedical Engineering
- Effects of 24 Months of Treatment With Romosozumab Followed by 12 Months of Denosumab or Placebo in Postmenopausal Women With Low Bone Mineral Density: A Randomized, Double-Blind, Phase 2, Parallel Group Study
- (2018) Michael R McClung et al. JOURNAL OF BONE AND MINERAL RESEARCH
- FRAME Study: The Foundation Effect of Building Bone With 1 Year of Romosozumab Leads to Continued Lower Fracture Risk After Transition to Denosumab
- (2018) Felicia Cosman et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Effects of teriparatide and risedronate on new fractures in post-menopausal women with severe osteoporosis (VERO): a multicentre, double-blind, double-dummy, randomised controlled trial
- (2018) David L Kendler et al. LANCET
- Prediction of incident vertebral fracture using CT-based finite element analysis
- (2018) B. T. Allaire et al. OSTEOPOROSIS INTERNATIONAL
- Greater Gains in Spine and Hip Strength for Romosozumab Compared With Teriparatide in Postmenopausal Women With Low Bone Mass
- (2017) Tony M Keaveny et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Romosozumab (sclerostin monoclonal antibody) versus teriparatide in postmenopausal women with osteoporosis transitioning from oral bisphosphonate therapy: a randomised, open-label, phase 3 trial
- (2017) Bente L Langdahl et al. LANCET
- Eighteen Months of Treatment With Subcutaneous Abaloparatide Followed by 6 Months of Treatment With Alendronate in Postmenopausal Women With Osteoporosis
- (2017) Felicia Cosman et al. MAYO CLINIC PROCEEDINGS
- Romosozumab or Alendronate for Fracture Prevention in Women with Osteoporosis
- (2017) Kenneth G. Saag et al. NEW ENGLAND JOURNAL OF MEDICINE
- Vertebral Fractures: Clinical Importance and Management
- (2016) D.L. Kendler et al. AMERICAN JOURNAL OF MEDICINE
- Bone mechanical properties and changes with osteoporosis
- (2016) Georg Osterhoff et al. INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED
- Finite Element Analysis of Denosumab Treatment Effects on Vertebral Strength in Ovariectomized Cynomolgus Monkeys
- (2016) David C Lee et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Effects of Romosozumab Compared With Teriparatide on Bone Density and Mass at the Spine and Hip in Postmenopausal Women With Low Bone Mass
- (2016) Harry K Genant et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Romosozumab Treatment in Postmenopausal Women with Osteoporosis
- (2016) Felicia Cosman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Further reductions in nonvertebral fracture rate with long-term denosumab treatment in the FREEDOM open-label extension and influence of hip bone mineral density after 3 years
- (2015) S. Ferrari et al. OSTEOPOROSIS INTERNATIONAL
- Romosozumab in Postmenopausal Women with Low Bone Mineral Density
- (2014) Michael R. McClung et al. NEW ENGLAND JOURNAL OF MEDICINE
- Femoral and Vertebral Strength Improvements in Postmenopausal Women With Osteoporosis Treated With Denosumab
- (2013) Tony M Keaveny et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Microstructural Failure Mechanisms in the Human Proximal Femur for Sideways Fall Loading
- (2013) Shashank Nawathe et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Assessment of incident spine and hip fractures in women and men using finite element analysis of CT scans
- (2013) David L Kopperdahl et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Relationship between bone mineral density changes with denosumab treatment and risk reduction for vertebral and nonvertebral fractures
- (2011) Matthew Austin et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Biomechanical computed tomography-noninvasive bone strength analysis using clinical computed tomography scans
- (2010) Tony M. Keaveny Annals of the New York Academy of Sciences
- Single-dose, placebo-controlled, randomized study of AMG 785, a sclerostin monoclonal antibody
- (2010) Desmond Padhi et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Influence of vertical trabeculae on the compressive strength of the human vertebra
- (2010) Aaron J Fields et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Which fractures are most attributable to osteoporosis?
- (2010) Amy H. Warriner et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Effects of teriparatide versus alendronate for treating glucocorticoid-induced osteoporosis: Thirty-six-month results of a randomized, double-blind, controlled trial
- (2009) Kenneth G. Saag et al. ARTHRITIS AND RHEUMATISM
- Quantifying the material and structural determinants of bone strength
- (2009) Mary L. Bouxsein et al. BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY
- Reanalysis precision of 3D quantitative computed tomography (QCT) of the spine
- (2008) Klaus Engelke et al. BONE
- Once-Monthly Oral Ibandronate Improves Biomechanical Determinants of Bone Strength in Women with Postmenopausal Osteoporosis
- (2008) E. Michael Lewiecki et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started